Last reviewed · How we verify

NCT05745025

rTMS and Rehabilitation for Individuals With CRPS Type 1

Status unknown NA Last updated 30 August 2023
What this trial tests

NA trial testing Repeated Transcranial Magnetic Stimulation in Complex Regional Pain Syndrome Type I in 20 participants. Status unknown.

Timeline
28 February 2023
Primary endpoint
1 February 2025
1 August 2025

Quick facts

Lead sponsorState University of New York - Upstate Medical University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment20
Start date28 February 2023
Primary completion1 February 2025
Estimated completion1 August 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

State University of New York - Upstate Medical University

Who can join

18 and older, any sex, with Complex Regional Pain Syndrome Type I. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Subjects with complex regional pain syndrome (CRPS) Type 1 will be randomized to receive repeated transcranial magnetic stimulation (rTMS) followed by rehabilitation or sham rTMS followed by rehabilitation. Treatment will last for 4 weeks, with the first week including 4 rTMS treatments and 2 rehabilitation treatments. Subsequent weeks will include 2 rTMS treatments followed by 2 rehabilitation treatments. Outcome measures will include pain ratings, PROMIS questionnaires, global rating of change, and grip strength or 1 repetition maximum leg press.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Repeated Transcranial Magnetic Stimulation

Trials testing the same drug.

Other recruiting trials for Complex Regional Pain Syndrome Type I

Currently open trials in the same condition.

Other State University of New York - Upstate Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05745025.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing